You are here » Home » Companies » Company Overview » Scandent Imaging Ltd

Scandent Imaging Ltd.

BSE: 516110 Sector: Health care
NSE: N.A. ISIN Code: INE146N01016
BSE LIVE 10:06 | 23 Aug 16.10 -0.80
(-4.73%)
OPEN

16.20

HIGH

16.20

LOW

16.10

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 16.20
PREVIOUS CLOSE 16.90
VOLUME 200
52-Week high 22.50
52-Week low 11.75
P/E 94.71
Mkt Cap.(Rs cr) 52
Buy Price 0.00
Buy Qty 0.00
Sell Price 16.10
Sell Qty 4829.00
OPEN 16.20
CLOSE 16.90
VOLUME 200
52-Week high 22.50
52-Week low 11.75
P/E 94.71
Mkt Cap.(Rs cr) 52
Buy Price 0.00
Buy Qty 0.00
Sell Price 16.10
Sell Qty 4829.00

Scandent Imaging Ltd. (SCANDENTIMAGING) - Company History

Established in 1982 as a partnership firm, Pharma Offset became a public limited company in Sep.'94. It was promoted by Rashmikant C Doshi and Uday M Raval. The company is engaged in manufacturing, processing, printing and packaging products. The company's product profile consists of cartons, pharmaceutical sales promotion literature, primary packaging materials, etc. The company undertook an expansion-cum-modernisation programme in 1994-95. It came out with a public issue in Jan.'95 to part-finance the project. Pharma Offset supplies its products to reputed pharmaceutical companies like Lyka Labs, Dolphin Laboratories and to multi-nationals like Parke-Davis, Sandoz, Merind, Fulford (India), etc. The company has entered into a firm tie-up with Lyka Labs and Dolphin Laboratories for an offtake of upto 60% of the expanded capacity. In 1998-99, the company commenced an additional activity of trading in chemicals and bulk drugs. During the year 1999-2000, the company has changed its name to Pharma Com (India) Ltd.